Short Term Strategy · Research Note
Ahluwalia Contr.
Holding horizon · 1m · 3m · 6mTarget: Active, high-probability setups
This name has since left the Short Term Strategy screen — the note is kept for reference.
“The intelligent investor is a realist who sells to optimists and buys from pessimists.”
— Benjamin Graham
₹580
₹4,025.95 Cr
17.89×
1.95×
23.02%
When the Builder's Own Share Price Falls Off the Scaffold
Ahluwalia Contracts builds the very things it cannot afford to have collapse — metro depots, hospitals, hotels, IT parks, automated car parks. There is a certain irony, then, that over the past twelve months its share price has done exactly what a good building must never do: fall. Down 36% in a year, from a high of ₹1,078 to a stone's throw above its 52-week low of ₹590. We are recommending it into the *Short Term Strategy* book — a one-to-six-month window — and the whole case rests on that gap between what the business is worth and where fear has parked the quote.
Think of this company as the contractor your housing society hires. You hand over the plans and the money; they bring the labour, the cement, the cranes and the deadline. They do not own the flat at the end — they earn a fee for putting it up correctly and on time. Ahluwalia does this at industrial scale for governments and private clients alike, and it does it while carrying almost no debt, which for a contractor is like a mason who never borrows another man's ladder.
The Order Book Grew; The Market Stopped Clapping
Look past the price chart and the business itself has been anything but sickly. Sales have marched from ₹1,060 crore in FY2015 to ₹4,686 crore on a trailing basis — a tenfold decade compounding at 14%, and a brisker 18% over the last five years and 17% over three. This is not a company running out of work. Revenue in FY2026 clocked ₹4,565 crore against ₹4,099 crore the year prior. The construction, in the literal sense, keeps happening.
What tripped the share was the *profit* line, not the top line. Net profit leapt to ₹375 crore in FY2024, then fell hard to ₹202 crore in FY2025 before recovering to ₹266 crore in FY2026, with trailing profit at ₹225 crore. Trailing profit growth of just 1% tells you the earnings engine coughed. The market, as it tends to do, extrapolated one bad stretch into permanence and marked the stock down a third. That is the setup a short-term value buyer waits for: a real business, a temporary stumble, a permanent-looking price.
What You Pay Versus What You Usually Pay
Here is the arithmetic that earns this name a place. The stock trades at 17.8 times earnings today. Over the past five years its own median multiple has been 23.4, and over ten years, 22.7. So you are buying Ahluwalia at roughly a 24% discount to its five-year normal and about 22% below its ten-year normal. The company has not become a worse business — its ROCE sits at a healthy 20.4%, and it is almost debt-free — yet Mr. Market is asking noticeably less for a rupee of its earnings than he has for most of the last decade.
Now the part we always insist on checking, because it separates honest compounding from illusion. The equity capital has sat at ₹13 crore in every single year from FY2015 to FY2026 — utterly flat. No rights issues, no quiet dribble of new shares, no dilution nibbling at your slice. Every rupee of that growing sales base belongs to the same number of owners it always did. That is rarer than it should be, and it deserves a nod.
The Warts, Named Plainly
We will not pretend this is a flawless picture. Return on equity is 13.8% and has hovered near 14% for a decade — respectable, not thrilling, and the gap between that and the 20.4% ROCE tells you the balance sheet is under-geared, sitting on cash rather than pressing its advantage. Contingent liabilities of ₹3,161 crore loom on the notes — the ordinary claims and disputes of contracting life, but a number to respect given the market cap of ₹4,013 crore. The dividend is a rounding error at 0.12% yield and 1.55% of profits paid out, so nobody is buying this for income. And a contractor's profits are lumpy by nature — project timing, client payments and cost inflation can swing a quarter, exactly as they did in FY2025.
Why We Are Buying, and For How Long
The tell is in who is arriving as the public panics. Promoters have held their 55.32% stake unmoved. Foreign institutions have raised their holding from 12.60% to 14.05% while the price bled. This is a debt-free builder, growing sales at a mid-teens clip, trading a fifth below its own long-run multiple, with a stumble in earnings that already shows signs of mending — FY2026 profit up on FY2025.
For a one-to-six-month holding, that is the whole thesis: a sound business on temporary sale, where reversion to its ordinary valuation does the work. Buy the discount, respect the lumpiness, and do not marry a contractor.